Digital Music Therapy Improves Stroke Recovery

Digital Music Therapy Improves Stroke Recovery

forbes.com

Digital Music Therapy Improves Stroke Recovery

InTandem, a digital platform using Rhythmic Auditory Stimulation (RAS) via music, is now available via prescription for stroke-related gait impairment; developed by Brian Harris at Spaulding Rehabilitation Hospital and now available to the 3.5 million chronic stroke survivors in the US.

English
United States
TechnologyHealthDigital HealthAlzheimer'sMusic TherapyNeurological DiseasesStroke RehabilitationSound Technology
Spaulding Rehabilitation HospitalHarvard Medical SchoolMedrhythmsLovell Government ServicesLapsi HealthCognito
Brian HarrisOwen MccarthyJhonatan Bringas DimitriadisDiana Van StijnRalph KernEd BoydenLi-Huei Tsai
How is music therapy, specifically RAS, impacting stroke rehabilitation and patient outcomes?
Music therapy, specifically Rhythmic Auditory Stimulation (RAS), has shown significant promise in stroke rehabilitation, improving gait speed and symmetry in patients beyond other treatments. This led to the creation of InTandem, a digital RAS platform now available via prescription for stroke-related gait impairment, offering hope to the 3.5 million chronic stroke survivors in the US.
What challenges were addressed in developing accessible digital platforms like InTandem for delivering RAS therapy?
The success of RAS in stroke rehabilitation highlights the untapped potential of music and rhythm in neurological recovery. InTandem's digital platform addresses accessibility challenges, expanding access to this effective therapy for a wider patient population, particularly chronic stroke survivors. This innovation demonstrates how sound-based interventions can revolutionize healthcare.
What are the potential future applications of sound-based therapies in neurological rehabilitation, considering the success of InTandem and similar innovations?
Future applications of RAS and similar sound-based therapies could extend beyond stroke rehabilitation, potentially impacting other neurological conditions. The development of digital platforms like InTandem points towards a future where personalized, at-home therapies become more widely available, potentially reducing healthcare disparities and improving patient outcomes. Further research exploring the mechanisms and efficacy of RAS across various neurological diseases is warranted.

Cognitive Concepts

2/5

Framing Bias

The article presents a generally positive framing of the potential of sound and rhythm-based technologies in treating neurological illnesses. The success stories and positive quotes from company representatives contribute to this optimistic perspective. While this is not necessarily biased, presenting potential limitations or challenges alongside the successes would create a more balanced perspective.

2/5

Language Bias

The language used is generally positive and enthusiastic towards the potential of sound-based technologies. Words like "profound," "dramatically," and "hopeful" are used frequently. While this enthusiasm is understandable, using more neutral language in certain sections would enhance objectivity. For instance, instead of "dramatically improved," the article could say "showed significant improvement.

2/5

Bias by Omission

The article focuses on a few specific examples of sound-based medical technologies, which might inadvertently downplay other promising approaches or ongoing research in neurological treatment. While focusing on a few key examples is understandable due to space constraints, a brief mention of the broader landscape of neurological treatment research could improve the article's overall balance.

Sustainable Development Goals

Good Health and Well-being Very Positive
Direct Relevance

The article highlights multiple innovative uses of sound and rhythm-based technologies to improve neurological health, treat stroke-related gait impairment, and potentially slow the progression of neurodegenerative diseases like Alzheimer's. These advancements directly contribute to improved health outcomes and quality of life for patients suffering from neurological illnesses.